Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-08-16
2005-08-16
Chernyshev, Olga N. (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007210, C436S501000, C436S503000, C436S504000
Reexamination Certificate
active
06929922
ABSTRACT:
Methods are described for the use of transferrin binding as the basis for a diagnostic assay to identify pathologies consistent with demyelinating diseases including Multiple Sclerosis. In a specific embodiment the evaluation of transferrin binding, in brain tissue, is used in a method for the detection of multiple sclerosis.
REFERENCES:
patent: 4737456 (1988-04-01), Weng et al.
patent: 4813399 (1989-03-01), Gordon
Harrison's Principles of Internal Medicine, p. 1995-2000 (11th ed. 1987).
Bourdette, DN, et al., “Health Care Costs Of Veterans With Multiple Sclerosis: Implications For The Rehabilitation of MS.,” Arch Phys Med Rehabil, 74, pp. 26-31, 1993.
Wucherpfenning KW, Strominger JL. “Molecular Mimicry in T Cell Mediated Autoimmunity: Viral Peptides Activate Human T Cell Clones Specific for Myelin Basic Protein,”Cell80: 695-705, 1995.
Martin R, et al., “Immunological Aspects of Demyelinating Disease,”Annu Rev Immunol10:153-87, 1992.
Hafler DA, Weiner HL. “Immunologic Mechanisms and Therapy in Multiple Sclerosis.”Immunol Rev144:75-107, 1995.
Hohfeld R, et al. “The Role of Autoimmune T Lymphocytes in the Pathogenesis of Multiple Sclerosis,”Neurology45 (6 Suppl 6):S33-8, 1995.
Steinman L, “A Few Autoreactive Cells in an Autoimmune Infiltrate Control a Vast Population of Nonspecific Cells: a Tale of Smart Bombs and the Infantry,”Proc Natl Acad Sci USA93: 2253-6, 1996.
Hafler DA, et al., “TCR Usage in Human and Experimental Demyelinating Disease,”Immunol Today1996; 17: 152-9, 1996.
Padovan E, et al., “Expression of Two T Cell Receptor α Chains: Dual Receptor T Cells,”Science262:422-4, 1993.
Davodeau F, et al. “Dual T Cell Receptor β Chain Expression on Human T Lymphocytes,”J. Exp Med181: 1391-8, 1995.
Padovan E, et al., “Normal T Lymphocytes Can Express Two Different T Cell Receptor β Chains: Implications for the Mechansim of Allelic Exclusion”J Exp Med181: 1587-91, 1995.
Marrack P. et al.,The Staphylococcal Enterotoxins and Their Relatives[published erratum appears in Science 1990: 248 1066]Science248: 705-11, 1990.
Hoffman, M., ““Superantigens” May Shed Light on Immune Puzzle,”Science248:685-6, 1990.
Kotzin BL, et al., “Superantigens and Their Potential Role in Human Disease,”Adv. Immunol54:99-166, 1993.
Scherer MT, et al., “Superantigens: Bacterial and Viral Proteins That Manipulate the Immune System,”Annu Rev Cell Biol9:101-28, 1993.
Brocke S, et al., “Infection and Multipple Sclerosis: A Possible Role for Superantigens?,”Trends Microbiol2:250-4, 1994.
Thorpe JW, et al., “Serial Gadolinium-enhanced MRI of the Brain and Spinal Cord in Early Relapsing-Remitting Multiple Sclerosis,”Neurology46:378-8, 1996.
Wekerle H, et al., “Cellular Immune Reactivity Within the CNS,”Trends Neurosci9:271-7, 1986.
Butcher EC, Picker LJ., “Lymphocyte Homing and Homeostasis,”Science272:60-6, 1996.
Shrikant P, Benveniste EN, “The Central Nervous System as an Immunocompetent Organ. Role of Glial Cells in Antigen Presentation,”J Immunol157:1819-22, 1996.
Vass K, Lassmann H., “Intrathecal Application of Interferon Gamma. Progressive Apperance of MHC Antigens within the Rat Nervous System,”Am J Pathol137: 789-800, 1990.
Lassmann H, Rossler K, Zimprich F, Vass K., “Expression of Adhesion Molecules and Histocompatibility Antigens at the Blood-Brain Barrier,”Brain Pathol1:115-23, 1991.
Lassmann H., et al. , “Microglial Cells are a Component of the Perivascular Glia Limitans,”J Neurosci Res.28: 236-43, 1991.
Fabry Z, Raine CS, Hart MN, “Nervous Tissue as an Immune Compartment: the Dialect of the Immune Response in the CNS,”Immunol Today15:218-24, 1994.
Fontana A, Fierz W, Werkle H, “Astrocytes Present Myelin Basic Protein to Encephalitogenic T Cell Lines,”Nature307:273-6, 1984.
Weber F, et al., “Human Astrocytes are only Partially Component Antigen Presenting Cells: Possible Implications for Lesion Development in Multiple Sclerosis,”Brain117: 59-69, 1994.
Meinl E, et al., “Multiple Sclerosis: Immunomodulatory Effects of Human Astrocytes on T Cells,”Brain117:1323-32, 1994.
Kojima K, et al., “Experimental Autoimmune Panencephalitis and Uveoretinitis Transferred to the Lewis Rat by T Lymphocytes Specific for the S100β Molecule, a Calcium Binding Protein of Astroglia,”J Exp Med180:817-29, 1994.
Linington C, et al., “Augmentation of Demyelination in Rat Acute Allergic Encephalomyelitis by Circulating Mouse Monoclonal Antibodies Directed Against a Myelin/Oligodendrocyte Glycoprotein,”Am J. Pathol130:443-54, 1988.
Genain CP, et al., “Antibody Facilitation of Multiple Sclerosis-Like Lesions in a Nonhuman Primate,”J Clin Invest96: 2966-74, 1995a.
Linington C, et al., “T Cells Specific for the Myelin Oligodendrocyte Glycoprotein Mediate and Unusual Autoimmune Inflammatory Response in the Central Nervous System,”Euro J immunol23:1364-72, 1993.
Ozawa K, et al., “Petterns of Oligodendroglia Pathology in Multiple Sclerosis,”Brain117:1311-22, 1994.
Hohlfeld, R., “Biotechnological Agents For The Immunotherapy Of Multiple Sclerosis,”Brain, 120, pp. 865-916, 1997.
Douillard and Hoffman, “Basic Facts about Hybridomas,” inCompendium of Immunologyvol. II, ed. by Schwartz, pp. 119-141, 1981.
Kohler and Milstein, “Continous cultures of fused cells secreting antibody of predifined specificity,”Nature256: 495-499, 1975.
Kohler, G. et al., “Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion,”European Journal of Immunology6: 511-519, 1976.
Connor James R.
Hulet Stanley W.
Chernyshev Olga N.
Medlen & Carroll LLP
The Penn State Research Foundation
LandOfFree
Methods for the detection of demyelinating diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the detection of demyelinating diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the detection of demyelinating diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3523427